You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 43 No. 2, February 1986 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Neurochemistry of Dopamine in Huntington's Dementia and Normal Aging

Stephen M. Stahl, MD, PhD; Sue Thiemann, MS; Kym F. Faull, PhD; Jack D. Barchas, MD; Philip A. Berger, MD

Arch Gen Psychiatry. 1986;43(2):161-164.


Abstract



• We measured the dopamine metabolite homovanillic acid (HVA) in cerebrospinal fluid (CSF) before and after probenecid administration in normal controls and in patients with Huntington's disease. Baseline CSF HVA concentrations correlated positively with age in normal control subjects. Baseline CSF HVA concentrations were reduced in patients with Huntington's disease, and the degree of this reduction correlated with the severity of dementia and with the duration of disease. These results suggest that changes in the metabolism of dopamine by dopaminergic neurons may be associated with the dementia of Huntington's disease as well as with normal aging. These changes in dopaminergic functioning are apparently different in Huntington's disease than in normal aging and can be detected by measuring CSF HVA concentration.



Author Affiliations



From the Palo Alto Veterans Administration Medical Center, Norris Mental Health Clinical Research Center, and the Department of Psychiatry and Behavioral Sciences (Drs Stahl and Berger and Ms Theimann), and the Nancy Pritzker Laboratory of Behavioral Neurochemistry and the Department of Psychiatry and Behavioral Sciences (Drs Faull and Barchas), Stanford (Calif) University.


Footnotes



Accepted for publication Sept 28, 1984.

Reprint requests to Psychiatry Service, 4B2, Palo Alto Veterans Administration Medical Center, 3801 Miranda Ave, Palo Alto, CA 94304 (Dr Stahl).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Publishing Ethics in Psychiatry
Walter and Bloch
Aust N Z J Psychiatry 2001;35:28-35.
ABSTRACT | FULL TEXT  

Retraction
Stahl et al.
Arch Gen Psychiatry 1989;46:758-758.
ABSTRACT  

Predictability of Phenotype in Huntington's Disease
Farrer and Conneally
Arch Neurol 1987;44:109-113.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.